IKKα is further shown to critically mediate IL-1β signaling in KRAS-mutant tumor cells, culminating in marked MPE-promoting effects delivered by C-X-C chemokine motif ligand 1 (CXCL1), and in oncogenic addiction with mutant KRAS evident as drug resistance. This evidence concerns the gene CXCL1 and neoplasm.